These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448 [Abstract] [Full Text] [Related]
3. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens. Jawahar MS, Rajaram K, Sivasubramanian S, Paramasivan CN, Chandrasekar K, Kamaludeen MN, Thirithuvathas AJ, Ananthalakshmi V, Prabhakar R. Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733 [Abstract] [Full Text] [Related]
4. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis]. Wada M, Yosiyama T, Yosikawa M, Ogata H, Sugie T, Nakasono T, Sugita H. Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720 [Abstract] [Full Text] [Related]
5. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment]. Berkani M, Chaulet P, Darbyshire JH, Nunn A, Fox W. Rev Mal Respir; 1986 Nov; 3(2):73-85. PubMed ID: 3726263 [Abstract] [Full Text] [Related]
6. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years]. Brändli O, Haegi V, Villiger B, Bohn W, Baumann HR, Zäch R. Schweiz Med Wochenschr; 1989 Mar 11; 119(10):299-305. PubMed ID: 2652281 [Abstract] [Full Text] [Related]
7. Short-course chemotherapy in the treatment of Pott's paraplegia: report on five year follow-up. Rajeswari R, Balasubramanian R, Venkatesan P, Sivasubramanian S, Soundarapandian S, Shanmugasundaram TK, Prabhakar R. Int J Tuberc Lung Dis; 1997 Apr 11; 1(2):152-8. PubMed ID: 9441080 [Abstract] [Full Text] [Related]
8. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis. Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H. Int J Tuberc Lung Dis; 2002 Dec 11; 6(12):1102-9. PubMed ID: 12546119 [Abstract] [Full Text] [Related]
9. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society. Br J Dis Chest; 1984 Oct 11; 78(4):330-6. PubMed ID: 6386028 [Abstract] [Full Text] [Related]
10. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach. Santha T, Rehman F, Mitchison DA, Sarma GR, Reetha AM, Prabhaker R, Tuberculosis Research Centre, Indian Council of Medical Research. Trop Med Int Health; 2004 May 11; 9(5):551-8. PubMed ID: 15117298 [Abstract] [Full Text] [Related]
11. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade. Snider DE, Zierski M, Graczyk J, Bek E, Farer LS. Eur J Respir Dis; 1986 Jan 11; 68(1):12-8. PubMed ID: 3512281 [Abstract] [Full Text] [Related]
12. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report. Teo SK. Int J Tuberc Lung Dis; 1999 Feb 11; 3(2):126-32. PubMed ID: 10091877 [Abstract] [Full Text] [Related]
13. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report. Ige OM, Bakare NA, Onadeko BO. Afr J Med Med Sci; 2000 Mar 11; 29(1):51-3. PubMed ID: 11379469 [Abstract] [Full Text] [Related]
14. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H. Kekkaku; 2003 Oct 11; 78(10):611-7. PubMed ID: 14621568 [Abstract] [Full Text] [Related]
15. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy. Migliori GB, Espinal M, Danilova ID, Punga VV, Grzemska M, Raviglione MC. Int J Tuberc Lung Dis; 2002 Oct 11; 6(10):858-64. PubMed ID: 12365571 [Abstract] [Full Text] [Related]
16. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)]. Kekkaku; 1980 Jan 11; 55(1):7-13. PubMed ID: 6988627 [No Abstract] [Full Text] [Related]
17. [Results of short-term tuberculosis therapy with isoniazid, rifampicin and pyrazinamide]. Brändli O, Dreher D, Morger D. Schweiz Med Wochenschr; 1993 Jun 26; 123(25):1300-6. PubMed ID: 8341998 [Abstract] [Full Text] [Related]
18. [Short-course chemotherapy of tuberculosis with pyrazinamide]. Asai S, Futsuki Y, Tomari S, Araki J. Nihon Rinsho; 1998 Dec 26; 56(12):3087-90. PubMed ID: 9883615 [Abstract] [Full Text] [Related]
19. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months. Nolan CM, Goldberg SV. Int J Tuberc Lung Dis; 2002 Nov 26; 6(11):952-8. PubMed ID: 12475140 [Abstract] [Full Text] [Related]
20. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy. Swaminathan S, Deivanayagam CN, Rajasekaran S, Venkatesan P, Padmapriyadarsini C, Menon PA, Ponnuraja C, Dilip M. Natl Med J India; 2008 Nov 26; 21(1):3-8. PubMed ID: 18472696 [Abstract] [Full Text] [Related] Page: [Next] [New Search]